The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Rocket Pharmaceuticals Inc (NASDAQ: RCKT) was $6.50 for the day, down -3.35% from the previous closing price of $6.72. In other words, the price has decreased by -$3.35 from its previous closing price. On the day, 3.22 million shares were traded.
Ratios:
Our analysis of RCKT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.19 and its Current Ratio is at 9.19. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on March 12, 2025, initiated with a Outperform rating and assigned the stock a target price of $50.
On December 30, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $32.
On December 18, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $29.Jefferies initiated its Buy rating on December 18, 2024, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 ’25 when Schwartz Jonathan David bought 1,582 shares for $6.53 per share.
Shah Gaurav bought 3,621 shares of RCKT for $23,636 on May 16 ’25. On May 16 ’25, another insider, Wilson Martin, who serves as the Officer of the company, bought 946 shares for $6.53 each.
Stock Price History:
Over the past 52 weeks, RCKT has reached a high of $26.98, while it has fallen to a 52-week low of $4.55. The 50-Day Moving Average of the stock is -8.63%, while the 200-Day Moving Average is calculated to be -50.08%.
Shares Statistics:
A total of 106.75M shares are outstanding, with a floating share count of 99.76M. Insiders hold about 7.22% of the company’s shares, while institutions hold 93.37% stake in the company.
